Vascular Birthmark Latest Advances

Soft tissue atrophy following intralesional corticosteroid injection for infantile hemangioma: A retrospective cohort study.

Journal: JAAD international

Published: January 19, 2026

Discussion: Long-Term Outcomes of Oral Propranolol for Facial Infantile Hemangioma.

Journal: Plastic and reconstructive surgery

Published: December 22, 2025

Clinical Management and Genetic Analysis of a Complex Case of Segmental Infantile Hemangioma with Subcutaneous Pelvic and Gluteal Tumefactions.

Journal: Advances in experimental medicine and biology

Published: November 22, 2025

RETRACTION: Our Experience With Propranolol for Infantile Hemangioma.

Journal: Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)

Published: November 15, 2025

Clinical characteristics, treatment outcomes and prognostic factors of ulcerated infantile hemangioma: 15 years of experience from a pediatric dermatology center in Hong Kong.

Journal: The Journal of dermatological treatment

Published: November 12, 2025

Topical propranolol for infantile hemangioma: a comprehensive review of mechanisms, clinical efficacy, and novel formulations.

Journal: Frontiers in pediatrics

Published: November 11, 2025

A Unique Case of Beard-Distributed Infantile Hemangioma With Subglottic Extension and Evaluation for PHACE Syndrome.

Journal: Ear, nose, & throat journal

Published: November 08, 2025

Diagnostic and therapeutic challenges of diffuse abdominal infantile hemangioma: a case report emphasizing multimodality imaging and multidisciplinary management.

Journal: Frontiers in pediatrics

Published: November 03, 2025

Exploring Nadolol as a Therapeutic Option for Infantile Hemangioma: A Narrative Review.

Journal: Cureus

Published: October 19, 2025

Correction to: Is it a hemangioma? A combined case report of soft tissue sarcomas mimicking infantile hemangioma.

Journal: Journal of surgical case reports

Published: October 13, 2025

Propranolol (1 mg/kg/day) with intralesional bleomycin versus propranolol monotherapy for infantile hemangioma: a randomized controlled trial.

Journal: Frontiers in pharmacology

Published: September 22, 2025

Systemic angiogenic protein changes following propranolol therapy in infantile hemangioma: a multi-target perspective.

Journal: Frontiers in pharmacology

Published: September 15, 2025